Clinical Trial Update: Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study [Phase 2]

View source ↗

Summary

This is a Phase 2 prospective open-label study evaluating the effectiveness and tolerability of Baricitinib for acute Alopecia Areata with active hair shedding.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Alopecia Areata | Phase 2 | Status: NOT_YET_RECRUITING